Periosteum contains mesenchymal stem cells (Pe-MSCs) that contribute to normal bone growth, healing, and turnover; understanding Pe-MSC capabilities may shed light over the treatment of bone defects using tissue engineering. Bone tissue regeneration needs in vitro bone precursors or stem cell coculture onto specific scaffolds but, despite extensive research in the field, very little is known about the matrix structure of the tissue-engineered tissues and the scaffold's effects on cell differentiation. To this purpose we have selected a clonal population (murine Pe-MSCs) that was seeded and differentiated onto an acellular bone scaffold. Cell differentiation was assessed after 3 months and 1 year by molecular, histological, biochemical, and biophysical analyses and results were compared with the same osteoinduced clonal cells cultured as cellular aggregates. Our data show that Pe-MSCs cultured onto acellular bone scaffold develop a complex three-dimensional matrix and an osteoblastic phenotype but do not produce hydroxyapatite (HA); moreover, they seem able to reabsorb the colonized bone scaffold. On the contrary, cells cultured as three-dimensional aggregates differentiate and produce osteoblastic markers and HA nanocrystals.
Get full access to this article
View all access options for this article.
References
1.
ArnsdorfE.J., JonesL.M, CarterD.R, JacobsC.R. The Periosteum as a cellular source for functional tissue engineering. Tissue Eng Part A, 15:2637. 2009.
2.
De BariC., Dell'AccioF., VanlauweJ., EyckmansJ., KhanI.M., ArcherC.W., JonesE.A., McGonagleD., MitsiadisT.A., PitzalisC., LuytenF.P.Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum, 54:1209. 2006.
3.
HutmacherD.W., SittingerM.Periosteal cells in bone tissue engineering. Tissue Eng, 9,Suppl 1:S45. 2003.
4.
BariC.D., Dell'AccioF., LuytenF.P.Human periosteum derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum, 44:85. 2001.
5.
ZhangX., XieC., LinA.S., ItoH., AwadH., LiebermanJ.R., RuberyP.T., SchwarzE.M., O'KeefeR.J., GuldbergR.E.Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J Bone Miner Res, 20:2124. 2005.
6.
VäänänennH.K.Osteoclast function: biology and mechanism. BilezikianJ.P., RaiszL.G., RodanG.A.Principles of bone biology. San Diego, CA: Academic Press, 1996; 103–113.
7.
HakedaY., KumegawaM.Osteoclasts in bone metabolism. Kaibogaku Zasshi, 66:215. 1991.
8.
ChambersT.J., ThompsonB.M., FullerK.The effect of substrate composition on bone resorption by rabbit osteoclasts. J Cell Sci, 70:61. 1984.
9.
ChambersT.J., FullerK.Bone cells predispose bone surfaces to resorption by exposure of mineral to osteoclastic contact. J Cell Sci, 76:155. 1985.
10.
MulariM.T.K., QuQ., HarkonenP.L., VaananenH.K.Osteoblast-like cells complete osteoclastic bone resorption and form new mineralized bone matrix in vitro. Calcif Tissue Int, 75:253. 2004.
11.
EvertsV., DelaisseJ.M., KorperW., JansenD.C., Tigchelaar-GutterW., SaftigP., BeertsenW.The bone lining cell: its role in cleaning howship's lacunae and initiating bone formation. J Bone Miner Res, 17:77. 2002.
12.
IwasakiM., NakaharaH., NakaseT., KimuraT., TakaokaK., CaplanA.I., OnoK.Bone morphogenetic protein 2 stimulates osteogenesis but does not affect chondrogenesis in osteochondrogenic differentiation of periosteum-derived cells. J Bone Miner Res, 9:1195. 1994.
13.
NakaharaH., DennisJ.E., BruderS.P., HaynesworthS.E., LennonD.P., CaplanA.I.In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. Exp Cell Res, 195:492. 1991.
14.
GruberR., MayerC., BobaczK., KrauthM.T., GraningerW., LuytenF.P., ErlacherL.Effects of cartilage-derived morphogenetic proteins and osteogenic protein-1 on osteochondrogenic differentiation of periosteum-derived cells. Endocrinology, 142:2087. 2001.
15.
HanadaK., SolchagaL.A., CaplanA.I., HeringT.M., GoldbergV.M., YooJ.U., JohnstoneB.BMP-2 induction and TGF-β1 modulation of rat periosteal cell chondrogenesis. J Cell Biochem, 81:284. 2001.
16.
VacantiC.A., BonassarL.J., VacantiM.P., ShufflebargerJ.Replacement of an avulsed phalanx with tissue-engineered bone. N Engl J Med, 344:1511. 2001.
17.
FerroF., FaliniG., SpelatR., D'AurizioF., PuppatoE., PandolfiM., BeltramiA.P., CesselliD., BeltramiC.A., Ambesi-ImpiombatoF.S., CurcioF.Biochemical and biophysical analysis of tissue engineered bone obtained from 3D culture of a subset of bone marrow mesenchymal stem cells. Tissue Eng Part A, 16:3657. 2010.
SørensenM.G., HenriksenK., SchallerS., HenriksenD.B., NielsenF.C., DziegielM.H., KarsdalM.A.Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood. J Bone Miner Metab, 25:36. 2007.
20.
ScottJ.E., DorlingJ.Differential staining of acid glycosaminoglycans (mucopolysaccharides) by alcian blue in salt solutions. Histochemie, 5:221. 1965.
21.
BanerjeeC., JavedA., ChoiJ.Y., GreenJ., RosenV., van WijnenA.J., SteinJ.L., LianJ.B., SteinG.S.Differential regulation of the two principal Runx2/Cbfa-1 N-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology, 142:4026. 2001.
22.
SitaraD., AliprantisA.O.Transcriptional regulation of bone and joint remodeling by NFAT. Immunol Rev, 233:286. 2010.
23.
NakagawaN., KinosakiM., YamaguchiK., ShimaN., YasudaH., YanoK., MorinagaT., HigashioK.RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem Biophys Res Commun, 253:395. 1998.
24.
AndersonD.M., MaraskovskyE., BillingsleyW.L., DougallW.C., TometskoM.E., RouxE.R., TeepeM.C., DuBoseR.F., CosmanD., GalibertL.A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature, 390:175. 1997.
25.
de VriesT., SchoenmakerT., HooibrinkB., LeenenP.J.N., EvertsV.Myeloid blasts are the mouse bone marrow cells prone to differentiate into osteoclasts. J Leukoc Biol, 85:919. 2009.
26.
RaggattL.J., PartridgeN.C.Cellular and molecular mechanisms of bone remodeling. J Biol Chem, 285:25103. 2010.
27.
DoddsR.A., ConnorJ.R., DrakeF., FieldJ., GowenM.Cathepsin K mRNA detection is restricted to osteoclasts during fetal mouse development. J Bone Miner Res, 13:673. 1998.
28.
DrakeF.H., DoddsR.A., JamesI.E., ConnorJ.R., DebouckC., RichardsonS., Lee-RykaczewskiE., ColemanL., RiemanD., BarthlowR., HastingsG., GowenM.Cathepsin K, but not cathepsin B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem, 271:12511. 1996.
29.
TezukaK., TezukaY., MaejimaA., SatoT., NemotoK., KamiokaH., HakedaY., KumegawaM.Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J Biol Chem, 269:1106. 1994.
30.
BossardM.J., TomaszekT.A., ThompsonS.K., AmegadzieB.Y., HanningC.R., JonesC., KurdylaJ.T., McNultyD.E., DrakeF.H., GowenM., LevyM.A.Proteolytic activity of human osteoclast cathepsin K. J Biol Chem, 271:12517. 1996.
31.
TanakaY., MaruoA., FujiK., NomiM., NakamuraT., EtoS., MinamiY.Intercellular adhesion molecule 1 discriminates functionally different populations of human osteoblasts: characteristic involvement of cell cycle regulators. J Bone Miner Res, 15:1912. 2000.
32.
ReyC.Calcium phosphate and bone mineral. Difference in composition, structure and properties. Biomaterials, 11:5. 1990.
33.
CurreyJ.D.Bones: Structure and mechanics. Princeton: Princeton University Press, 2002.
34.
DorozhkinS.V.Calcium orthophosphates. J Mat Sci, 42:1061. 2007.
SondergaardB.C., HenriksenK., WulfH., OestergaardS., SchurigtU., BrauerR., DanielsenI., ChristiansenC., QvistP., KarsdalM.A.Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation. Osteoarthritis Cartilage, 14:738. 2006.
37.
HaeckelC., KruegerS., BuehlingF., BroemmeD., FrankeK., SchuetzeA., RoeseI., RoessnerA.Expression of cathepsin K in the human embryo and fetus. Dev Dyn, 216:89. 1999.
38.
ZanottiS., Smerdel-RamoyaA., CanalisE.Reciprocal regulation of Notch and nuclear factor of activated T-cells (NFAT) c1 transactivation in osteoblasts. J Biol Chem, 286:4576. 2011.
39.
Smerdel-RamoyaA., ZanottiS., CanalisE.Connective tissue growth factor (CTGF) transactivates nuclear factor of activated T-cells (NFAT) in cells of the osteoblastic lineage. J Cell Biochem, 110:477. 2010.
40.
KarlströmE., Ek-RylanderB., WendelM., AnderssonG.Isolation and phenotypic characterization of a multinucleated tartrate-resistant acid phosphatase-positive bone marrow macrophage. Exp Hematol, 39:339. 2011.
41.
BaylinkD., StaufferM., WergedalJ., RichC.Formation, mineralization, and resorption of bone in vitamin D-deficient rats. J Clin Invest, 49:1122. 1970.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
